Unresectable Stage III
1 clinical trials · Condition
◉ Watch Unresectable Stage III
| Record | Firm | Date |
|---|---|---|
| An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma (NCT01136967) | Eisai Inc. | 2010-08-01 |
Track Unresectable Stage III automatically
Every clearance here is in the API, with alerts when new ones post.